Skip to main content

Norton Rose Fulbright has advised China Mengniu Dairy on its plan to buy infant formula maker Bellamy’s Australia for A$1.43 billion ($983 million), with Allens advising the seller.

According to Reuters, the deal offers Bellamy’s investors a way to cash out of a prospect that has spent years awaiting approval to sell product in its target market, China, while giving Mengniu a prized consumer brand. Foreign formula remains sought after in China following a contamination scandal a decade ago.

The NRF team was led by Sydney-based corporate/M&A partner John Elliott, with Hong Kong partners Psyche Tai and Peter Haslam advising on local regulations and the finance aspects, respectively. The Allens team was led by partners Guy Alexander and Tom Story.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

JSA, CAM, Khaitan act on $2.3 bln Ayana Renewable sale

by Nimitt Dixit |

Indian law firm JSA Advocates & Solicitors has advised ONGC NTPC Green on its $2.3 billion acquisition of Ayana Renewable Power from National Investment and Infrastructure Fund (NIIF), British International Investment and private equity firm Eversource Capital.

Kirkland, Links, Llinks, CM act on CATL’s planned $5 bln HK IPO

Kirkland & Ellis and Llinks Law Offices are advising Chinese EV battery giant Contemporary Amperex Technology (CATL) on its proposed initial public offering on the Hong Kong Stock Exchange, with Linklaters and CM Law Firm advising the underwriters.

Paul Hastings, Latham lead on $827 mln LG CNS Korea IPO

Paul Hastings has advised South Korean tech services firm and LG Group member company LG CNS on its 1.2-trillion-won ($827 million) global offering and listing on the Korea Exchange, with Latham & Watkins advising the bookrunners.